Childhood-Onset Motor and Cognitive Regression Syndrome with Extrapyramidal Movement Disorder

Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder is a very rare brain disease that starts in young children. At first, many children develop almost normally or only a little slowly. Later, usually between 2 and 7 years of age, they slowly begin to lose skills they already had. They may lose language, thinking skills, and movement skills like walking, running, or using their hands. Doctors call this “regression.” MalaCards+2zfin.org+2

This condition happens because of a change (mutation) in a gene called UBTF. This gene is important for making parts of the cell that build proteins. When the gene does not work in the normal way, brain cells in the thinking areas (cerebrum) and balance areas (cerebellum) slowly become damaged. Over time, brain scans show that these parts of the brain shrink, which is called brain atrophy. Children then develop very serious disability, with loss of walking, loss of speech, and severe problems with thinking and daily activities. zfin.org+2PMC+2

In this syndrome, children also have extrapyramidal movement problems. This means they can have extra, uncontrolled movements or stiff movements due to damage in deep brain movement centers (basal ganglia). These movements can look like twisting, jerking, shaking, or Parkinson-like slowness and stiffness. Genetic Diseases Info Center+2MalaCards+2

Other names

Doctors and researchers use several names for the same disease. These names can appear in different articles or medical reports:

• Childhood-onset neurodegeneration with brain atrophy (CONDBA) – this is a common short name. “Neurodegeneration” means the brain cells are slowly dying. “Brain atrophy” means the brain becomes smaller over time. MalaCards+2zfin.org+2

• UBTF-related disorder – this name reminds doctors that the disease is linked to a harmful change in the UBTF gene. PMC+2Abcam+2

• UBTF neuroregression syndrome (UNS) – “neuroregression” means the nervous system loses skills after they were already learned. This term is used in newer research papers. PMC+1

• Neurodegeneration, childhood-onset, with brain atrophy – this is another formal name used in disease databases such as OMIM, MedGen, and disease ontologies. NCBI+2MalaCards+2

All these names describe the same core problem: a childhood disease with loss of brain tissue and slow loss of movement and thinking abilities linked to UBTF gene changes. MalaCards+2PMC+2

Types or clinical patterns

There are no strict “official” types yet, but doctors see some patterns. These patterns help them describe how the disease looks in different children. MalaCards+2PMC+2

• Classic childhood-onset pattern
  In many children, early development is normal or only slightly delayed. Then, between 2 and 7 years of age, they begin to lose both movement and thinking skills. They slowly stop walking, stop speaking, and become fully dependent on others for care. Brain scans show clear shrinking of the cerebrum and cerebellum. MalaCards+2zfin.org+2

• Early-severe pattern
  Some children show problems earlier and progress faster. They may have more severe regression, early seizures, and very quick loss of language and walking. They reach a severe disability level over a few years, with marked brain atrophy on MRI. Springer Link+2PMC+2

• Relatively milder or slower pattern
  A few reported children have a somewhat slower progression. They still lose skills, but the speed may be slower, or some abilities remain for longer. These children may retain limited communication or some motor function for more years. MalaCards+2PMC+2

• Patterns with extra features (for example hearing loss or marked seizures)
  New case reports show that some children also develop extra problems, such as sensorineural hearing loss or special EEG changes, on top of the usual regression. Doctors think these features may reflect small differences in how the UBTF change affects the nervous system in each child. MalaCards+2PMC+2

Causes and disease mechanisms

For this disease, there is one main root cause: a harmful change (mutation) in the UBTF gene. The 20 points below describe this single cause and the different steps in how it harms the brain. They are not 20 separate outside causes, but 20 pieces of the same disease process. zfin.org+2PMC+2

1. UBTF gene mutation
   The UBTF gene gives instructions to make a protein called upstream binding transcription factor. A specific change in this gene (often the E210K variant) alters the protein so it does not work in the normal way. This faulty gene is the central cause of the disease. zfin.org+2PMC+2

2. Autosomal dominant pattern
   The disease follows an autosomal dominant model. This means that having just one changed copy of the UBTF gene in each cell is enough to cause the condition. If a parent has the mutation, each child has a 50% chance of inheriting it, although many cases are new (de novo). NCBI+2MalaCards+2

3. De novo (new) mutations
   In many children, the UBTF variant is not found in either parent. It arises for the first time in the egg or sperm or very early in the embryo. These “de novo” changes are not caused by anything the parents did, and they could not have prevented it. MalaCards+2PMC+2

4. Gain-of-function effect
   Research suggests that the UBTF E210K variant is a “gain-of-function” mutation. This means the protein becomes over-active or behaves in an abnormal way, instead of simply being missing. This abnormal activity disrupts normal control of certain genes inside brain cells. PMC+1

5. Abnormal ribosomal RNA (rRNA) transcription
   UBTF helps turn on genes that make ribosomal RNA, a key part of ribosomes, which are the cell’s protein factories. When UBTF is altered, rRNA production becomes disordered. This leads to problems in making ribosomes, especially in sensitive brain cells. PMC+1

6. Impaired ribosome biogenesis
   Because rRNA is not made correctly, ribosome assembly is disturbed. Brain cells then cannot produce proteins in the right amount or at the right time. Over many years, this chronic stress contributes to brain cell damage and death. PMC+1

7. Selective vulnerability of neurons
   Not all tissues are equally affected. Neurons in the cortex, cerebellum, and basal ganglia seem especially vulnerable to UBTF changes. These areas control movement, balance, language, and thinking, so damage here matches the main symptoms of the disease. MalaCards+2zfin.org+2

8. Progressive cortical atrophy
   Over time, many nerve cells in the outer brain (cortex) are lost. MRI scans show shrinking of these areas. This progressive cortical atrophy is a key reason for loss of language, learning, and higher thinking skills. MalaCards+2zfin.org+2

9. Progressive cerebellar atrophy
   The cerebellum, which helps control balance and coordination, also becomes smaller. This is linked to problems such as unsteady walking (ataxia) and problems with fine motor skills and speech coordination. MalaCards+2zfin.org+2

10. Thinning of the corpus callosum
    Some children show thinning of the corpus callosum, the big band of nerve fibers connecting the two sides of the brain. When this structure is affected, communication between brain hemispheres is less efficient, adding to cognitive and motor problems. Genetic Diseases Info Center+2Orpha+2

11. Basal ganglia circuit disruption
    The basal ganglia are deep brain structures that help smooth and control movement. UBTF-related damage here leads to extrapyramidal signs like dystonia, chorea, and Parkinson-like stiffness and slowness. Genetic Diseases Info Center+2MalaCards+2

12. Neurodevelopmental regression window (age 2–7)
    The disease often starts when the brain is still rapidly developing and forming networks. This timing makes the damage more harmful, because it removes skills that were just recently learned, such as talking and walking. MalaCards+2zfin.org+2

13. Possible genetic modifiers
    Some children have more severe or different features than others, even with similar UBTF variants. This suggests that other genes in the background may slightly change how strongly the UBTF mutation shows its effects, although these modifiers are not yet clearly known. MalaCards+2PMC+2

14. Cellular stress and energy imbalance
    When protein production is disturbed, cells experience chronic stress in structures like the nucleolus and endoplasmic reticulum. Neurons may then struggle with energy use and normal repair, which can speed up cell death. PMC+1

15. Abnormal brain network activity (including seizures)
    Some children develop seizures. This means brain networks fire in abnormal and highly synchronized ways. Seizures themselves can further worsen cognitive and language regression, adding to the impact of the UBTF mutation. PMC+2springermedizin.de+2

16. Loss of synaptic connections
    As neurons become sick, they lose connections (synapses) with other cells. This reduces the brain’s ability to process information and send signals smoothly, contributing to both movement and thinking problems. PMC+1

17. Chronic progression over years
    The UBTF-related changes do not appear and stop quickly; they continue over many years. This slow, long-term progression explains why children keep losing abilities and do not regain lost skills. MalaCards+2PMC+2

18. Very low prevalence (extreme rarity)
    This disease is extremely rare, with well under one case per million people. Because it is so rare, families may wait a long time for a correct diagnosis, and many doctors may never see a case. The rarity is not a cause of symptoms, but it is a cause of diagnostic delay. MalaCards+1

19. Decreasing head growth (secondary microcephaly)
    In some children, measured head growth slows down compared with normal charts. This reflects ongoing brain tissue loss rather than a separate cause, but it is an important part of how the disease shows itself. Genetic Diseases Info Center+2MalaCards+2

20. No known environmental trigger
    At present, no specific food, infection, injury, or toxin is known to directly cause this syndrome. Environment may influence general health, but the core problem comes from the UBTF gene mutation. MalaCards+2PMC+2

Symptoms and signs

1. Motor regression (loss of movement skills)
   Children slowly lose skills like sitting, standing, walking, and using their hands. A child who could walk alone may now need help, use a wheelchair, or be unable to walk at all. MalaCards+2zfin.org+2

2. Cognitive regression (loss of thinking skills)
   Thinking and learning abilities go backwards. A child who could understand simple instructions or solve small tasks may later struggle with very basic concepts and daily activities. MalaCards+2zfin.org+2

3. Loss of language and speech
   Children may first use words or short sentences and then slowly stop speaking. They may also not understand spoken language as before. In severe stages, they can become completely non-verbal. MalaCards+2zfin.org+2

4. Severe intellectual disability
   Over time, most affected children develop profound intellectual disability. They need help with all daily activities, including eating, dressing, toileting, and moving. MalaCards+2uniprot.org+2

5. Dystonia (twisting muscle contractions)
   Dystonia causes involuntary twisting or abnormal postures of the arms, legs, neck, or face. It can make walking, sitting, and hand use very difficult and uncomfortable. Genetic Diseases Info Center+2MalaCards+2

6. Chorea (jerky, dance-like movements)
   Chorea is a movement problem with sudden, unpredictable jerks or fidgety movements. These movements can affect the arms, legs, or face and can interfere with purposeful actions like feeding or writing. Genetic Diseases Info Center+2MalaCards+2

7. Parkinson-like features (rigidity and slowness)
   Some children develop stiffness of muscles, slow movements, and reduced facial expression, similar to Parkinson’s disease. This can make walking and hand movements very slow and effortful. Genetic Diseases Info Center+2MalaCards+2

8. Ataxia (balance and coordination problems)
   Ataxia means unsteady or clumsy movement. Children may stagger when they walk, fall easily, or have trouble with coordinated actions like picking up small objects. This reflects cerebellar involvement. Genetic Diseases Info Center+2MalaCards+2

9. Dysarthria (slurred or difficult speech)
   If speech is still present, it may become slurred, slow, or hard to understand. This happens because muscles used for speech and coordination pathways in the brain are affected. Genetic Diseases Info Center+2MalaCards+2

10. Seizures (fits)
    Some children develop seizures, which may look like staring spells, sudden jerks, or full-body shaking. Seizures can appear at any time during the course of the illness and usually require anti-seizure medicine. Springer Link+2PMC+2

11. Behavioral changes
    Children may become more irritable, anxious, or withdrawn. They may lose interest in play, have difficulty sleeping, or show sudden mood changes. These behaviors are often part of the brain disease, not “bad behavior.” MalaCards+2PMC+2

12. Feeding and swallowing problems
    As motor control worsens, chewing and swallowing can become difficult. Children may cough when eating or drinking, take a very long time to finish meals, or need different food textures. MalaCards+2uniprot.org+2

13. Drooling and poor control of saliva
    Weak muscle control around the mouth and face can cause drooling. This is not just a social problem; it can lead to skin irritation and risk of choking. MalaCards+2uniprot.org+2

14. Slow head growth or secondary microcephaly
    In some children, head size percentiles drop over time. This reflects loss of brain volume rather than small head at birth. Health workers may notice this on regular growth chart checks. Genetic Diseases Info Center+2zfin.org+2

15. Complete dependence in late stages
    As the disease advances, children usually cannot walk, talk, or perform self-care. They often need full-time care for positioning, feeding, hygiene, and comfort. MalaCards+2zfin.org+2

Diagnostic tests

Doctors use a mix of clinical examination and tests to diagnose this syndrome, to rule out other conditions, and to confirm the UBTF gene change.

Physical exam

1. Full neurological examination
   The doctor checks muscle tone, reflexes, strength, coordination, and eye movements. They look for signs of dystonia, chorea, rigidity, and ataxia. The pattern of findings helps suggest a neurodegenerative disorder with extrapyramidal features. Genetic Diseases Info Center+2MalaCards+2

2. Developmental and cognitive assessment in clinic
   The doctor or psychologist asks about milestones (sitting, walking, talking) and watches the child play and follow instructions. Comparing current skills to past abilities shows the degree of regression. MalaCards+2zfin.org+2

3. Growth and head circumference measurement
   Height, weight, and head size are plotted on growth charts. Falling head circumference percentiles or weight loss may signal worsening brain atrophy or feeding problems. Genetic Diseases Info Center+2zfin.org+2

4. Observation of gait and posture
   If the child can still walk, the doctor observes how they stand, walk, and turn. They look for unsteadiness, stiff or slow steps, and abnormal postures that suggest extrapyramidal and cerebellar involvement. MalaCards+2uniprot.org+2

Manual and bedside functional tests

5. Muscle tone and passive movement testing
   The doctor gently moves the child’s arms and legs to feel for stiffness or unusual resistance. Increased tone (rigidity) or velocity-dependent resistance (spasticity) helps describe the type of movement disorder present. MalaCards+2uniprot.org+2

6. Coordination tests (finger-to-nose, heel-to-shin)
   If possible, the child is asked to touch their nose and the doctor’s finger, or slide the heel down the opposite shin. Clumsy, overshooting, or shaky performance supports cerebellar ataxia. MalaCards+2zfin.org+2

7. Simple balance and standing tests
   The doctor may ask the child to stand with feet together or in a narrow base, and may gently push the shoulders to see how they correct posture. Poor balance or falls suggest cerebellar and extrapyramidal dysfunction. MalaCards+2zfin.org+2

8. Standardized developmental or functional scales
   Tools such as motor function scales, adaptive behavior scales, or global developmental tests are used. Repeating these over time documents how fast the child is losing skills. MalaCards+2PMC+2

Laboratory and pathological tests

9. Basic blood tests (CBC, biochemistry)
   A complete blood count and basic chemistry panel help rule out other causes of regression such as metabolic disorders, infections, or organ failure. These tests are usually normal in UBTF-related disease but are important for differential diagnosis. MalaCards+2Springer Link+2

10. Metabolic and mitochondrial screening
    Tests like lactate, ammonia, amino acids, acylcarnitine profile, and some enzyme assays are often done to exclude other treatable mitochondrial or metabolic diseases. In UBTF syndrome, these tests are often normal or nonspecific. MalaCards+2Springer Link+2

11. Urine organic acids
    Doctors may check urine organic acids to rule out other neurodegenerative diseases (for example some types of 3-methylglutaconic aciduria). In UBTF-related neuroregression, these results are not specific, but help exclude other conditions. MalaCards+2xenbase-test.ucalgary.ca+2

12. Cerebrospinal fluid (CSF) analysis (when indicated)
    A lumbar puncture may be performed to look for infection, inflammation, or metabolic abnormalities in the CSF. In UBTF-related disease, CSF is often normal, but testing is useful to rule out other treatable causes of regression and seizures. Springer Link+2springermedizin.de+2

13. Genetic testing – targeted UBTF sequencing or gene panel
    This is the key confirmatory test. DNA from blood (or saliva) is analyzed to look for the known UBTF variant, such as c.628G>A (p.E210K), or other pathogenic UBTF changes. Many labs use neurodegeneration or intellectual disability gene panels, or whole-exome/genome sequencing, to detect this mutation. NCBI+3zfin.org+3PMC+3

14. Parental genetic testing
    Once a UBTF mutation is found in the child, the parents may also be tested. If neither parent has the variant, it is confirmed as a de novo change. This information is important for understanding recurrence risk in future pregnancies. MalaCards+2PMC+2

Electrodiagnostic tests

15. Electroencephalogram (EEG)
    EEG records the brain’s electrical activity. It is used to detect seizures or epileptic discharges, which are present in some children with this syndrome. EEG can also show background slowing, indicating global brain dysfunction. Springer Link+2PMC+2

16. Nerve conduction studies and electromyography (EMG) – when needed
    These tests measure how well nerves and muscles work. They are mainly used to rule out peripheral neuromuscular diseases if there is concern about muscle weakness. In UBTF disease, results are usually normal or nonspecific, helping to show that the main problem is in the brain. MalaCards+2uniprot.org+2

17. Evoked potentials (visual or auditory) in selected cases
    Evoked potentials test how the brain responds to visual or sound stimuli. Abnormal responses can show that pathways for vision or hearing are affected, which may be helpful if there are concerns about sensory decline. MalaCards+2uniprot.org+2

Imaging tests

18. Brain MRI (magnetic resonance imaging)
    MRI is a key test. It shows progressive shrinking (atrophy) of the cerebral cortex and cerebellum, and sometimes thinning of the corpus callosum. These findings support a diagnosis of childhood-onset neurodegeneration with brain atrophy. MalaCards+2zfin.org+2

19. Serial follow-up brain MRI
    Repeating MRI over several years can show how the brain changes over time. Worsening atrophy on follow-up scans matches the clinical picture of ongoing loss of movement and cognitive skills. MalaCards+2Springer Link+2

20. Additional imaging (for example spinal MRI, advanced research scans)
    In some cases, doctors may order spinal MRI to rule out spinal cord problems, or advanced research imaging techniques (such as diffusion or metabolic imaging) to better understand the disease. These tests are not always needed for routine diagnosis but can add information in complex cases. MalaCards+2Springer Link+2

Non-pharmacological treatments ( therapies and other approaches)

1. Physical therapy
   Physical therapy uses guided exercises, stretching, and positioning to keep muscles as flexible and strong as possible. The therapist helps the child practice sitting, standing, and walking in safe ways, sometimes with walkers or parallel bars. The purpose is to reduce stiffness, prevent contractures, and maintain mobility. The main mechanism is repeated, gentle movement that keeps joints moving through their full range, strengthens weak muscles, and retrains the brain–muscle connection through practice and feedback.PMC+1

2. Occupational therapy
   Occupational therapy focuses on daily life skills such as feeding, dressing, writing, or using switches and buttons. The therapist breaks each task into small, manageable steps and teaches easier ways to do them. The purpose is to keep the child as independent as possible in everyday activities. The mechanism is task-specific training: repeating real-life activities, using adaptive tools, and changing the task or environment so that the child can succeed even with limited strength or coordination.PMC+1

3. Speech and language therapy
   Speech therapists help with speech, understanding words, and safe swallowing. When speech becomes difficult, they introduce communication boards, picture cards, or electronic devices so the child can still express needs and feelings. The purpose is to protect communication and prevent choking or aspiration. The mechanism is targeted exercise of the muscles of the mouth, face, and throat, plus repeated practice of sounds, words, and safe swallowing patterns, sometimes combined with thickened fluids and posture changes.Global Genes+1

4. Augmentative and alternative communication (AAC)
   AAC includes low-tech tools (picture books, symbol boards) and high-tech devices (tablets with communication apps, eye-gaze systems). The purpose is to give the child a reliable voice when speech is weak or lost. The mechanism is simple: replace or support spoken words with symbols or text that the child can select by touch, switch, or eye movement, thus bypassing the motor difficulty of talking while still using the child’s understanding and thinking skills.Genopedia+1

5. Cognitive and developmental therapy
   Special educators and neuropsychologists provide activities that stimulate memory, attention, problem-solving, and play. Even if skills are declining, practice may slow the loss and keep some functions longer. The purpose is to support remaining cognitive skills and emotional well-being. The mechanism is repeated mental stimulation, structured play, and routine-based learning that strengthen remaining brain networks and help the child use strategies like repetition and visual supports.NCBI+1

6. Special education and individualized education plans (IEP)
   Children usually need special school support with smaller classes, extra time, physical help, and adapted materials. The purpose is to allow the child to learn at their own pace and ability level. The mechanism is adaptation: changing curriculum, teaching methods, classroom setup, and expectations so the child can participate despite motor and cognitive challenges.Genopedia+1

7. Orthotic devices and adaptive equipment
   Splints, braces, ankle–foot orthoses (AFOs), hand splints, special chairs, standing frames, and walkers help the child maintain posture and move more safely. The purpose is to prevent deformities and support mobility. The mechanism is external support: devices hold joints in healthier positions, reduce abnormal postures from dystonia or rigidity, and distribute pressure more evenly to protect skin and joints.PMC+1

8. Positioning and seating systems
   Custom wheelchairs and seating systems with headrests, side supports, and belts keep the child sitting safely and comfortably. The purpose is to prevent falls, pressure sores, and scoliosis. The mechanism is mechanical alignment: carefully shaped cushions and supports keep the spine and hips in better alignment, which reduces pain and makes breathing and swallowing easier.ERN RND+1

9. Respiratory physiotherapy
   When muscle weakness affects breathing or coughing, respiratory therapists teach breathing exercises, cough-assist devices, and chest physiotherapy. The purpose is to reduce the risk of chest infections and help clear mucus. The mechanism is physical clearance of secretions using controlled breathing, postural drainage, and mechanical aids that simulate a strong cough.PMC+1

10. Feeding and nutritional therapy
    Dietitians and feeding therapists evaluate calorie needs, swallowing safety, and growth. They may suggest thickened liquids, special textures, high-calorie foods, or feeding through a tube if needed. The purpose is to maintain healthy weight, prevent malnutrition, and lower aspiration risk. The mechanism is matching food type and feeding method to the child’s swallowing ability and energy needs, often using small, frequent meals and careful positioning.Global Genes+1

11. Behavioral therapy
    Psychologists or behavior therapists help manage irritability, frustration, repetitive behaviors, or self-injury. They use positive reinforcement, visual schedules, and calm routines. The purpose is to improve cooperation, reduce distress, and make daily care easier. The mechanism is learning-based: by linking desired behaviors with rewards and unwanted behaviors with calm, consistent limits, the brain learns new patterns over time.PMC+1

12. Sensory integration and play therapy
    Sensory-based therapies use swings, textured objects, music, and lights to give controlled sensory input. Play therapy uses games and toys to explore emotions. The purpose is to help the child feel calmer, better regulated, and more connected to others. The mechanism is gradual exposure to sensory input in a safe setting so the nervous system can process touch, sound, and movement more smoothly, reducing anxiety and overload.PMC+1

13. Hydrotherapy (aquatic therapy)
    Exercising in warm water supports the child’s weight and allows easier movement. Therapists guide walking, stretching, and balance exercises in the pool. The purpose is to improve mobility and comfort with less pain or fatigue. The mechanism is buoyancy and warmth: water reduces gravity’s pull and relaxes muscles, so stiff or weak limbs can move through a greater range with less effort.PMC

14. Task-specific gait and balance training
    Therapists may use treadmills with harness support, stepping over obstacles, or balance boards to train walking. The purpose is to keep walking ability as long as possible and reduce falls. The mechanism is repetitive practice of specific walking patterns, which strengthens the neural circuits in the brain and spinal cord that control gait, even when underlying disease is present.PMC+1

15. Family and caregiver training
    Parents and caregivers learn safe lifting, stretching, feeding, and communication strategies. The purpose is to prevent caregiver injury, improve home care, and reduce hospital visits. The mechanism is knowledge transfer: teaching practical skills and problem-solving so that home care follows the same principles used in the clinic.Global Genes+1

16. Psychological counseling for child and family
    Counseling supports emotional health, coping, and grief for both the child and family. The purpose is to manage stress, anxiety, sadness, and uncertainty about the future. The mechanism is talking, listening, and learning coping strategies such as relaxation, problem-solving, and seeking social support, which reduce the emotional burden of chronic illness.Global Genes+1

17. Sleep hygiene programs
    Sleep problems are common in neurodegenerative disorders. A sleep program sets regular bedtimes, calming routines, controlled light, and reduced screen time. The purpose is to improve sleep quality, which also improves mood and daytime function. The mechanism is aligning sleep with the body’s clock (circadian rhythm) and reducing stimulation before bed so the brain can slow down and fall asleep more easily.PMC+1

18. Environmental safety modifications
    Home changes such as grab bars, ramps, non-slip floors, mattress protectors, and safe bathroom setups reduce the risk of injury. The purpose is to prevent falls, fractures, and head injuries. The mechanism is risk reduction: removing trip hazards, adding supports, and making sure wheelchairs and beds are used correctly to keep the child safer.PMC+1

19. Social and community support programs
    Support groups, respite care, and community disability services help families manage the long-term demands of care. The purpose is to reduce isolation and caregiver burnout. The mechanism is shared experience and practical help, which give emotional relief and sometimes access to financial or educational resources.Global Genes+1

20. Palliative and supportive care planning
    Palliative care teams focus on comfort, symptom control, and family wishes, even while active treatment continues. The purpose is to improve quality of life at every stage. The mechanism is careful assessment of pain, distress, feeding, and breathing, plus advance care discussions, so treatment matches the family’s values and the child’s needs.Global Genes+1

---

Drug treatments

Very important: medicines below are examples of drugs used for symptoms seen in this syndrome (parkinsonism, dystonia, spasticity, seizures, behavior problems). None are specifically approved to “cure” this rare disease. Doses in children are always individualized by weight and must be decided only by a pediatric neurologist or similar specialist.

1. Carbidopa/levodopa (e.g., SINEMET, DHIVY)
   Carbidopa/levodopa is a standard treatment for parkinsonism. Levodopa is turned into dopamine inside the brain, while carbidopa prevents levodopa from being broken down in the body before it reaches the brain. In children with extrapyramidal rigidity and slowness, a neurologist may try low-dose carbidopa/levodopa to see if movements and stiffness improve. Dosing is carefully started low and slowly increased, usually given several times a day with or without food, depending on tolerance. Side effects may include nausea, low blood pressure, sleepiness, and abnormal involuntary movements (dyskinesias).FDA Access Data+1

2. Baclofen (oral solutions and tablets, e.g., LYVISPAH, FLEQSUVY, OZOBAX)
   Baclofen is a muscle relaxant that reduces spasticity by acting on GABA-B receptors in the spinal cord. It can decrease muscle tone and spasms in children with stiff limbs or painful spasms. Doses start very low and are slowly increased based on response and side effects, usually given three or four times daily. Main side effects include sleepiness, weakness, dizziness, low mood, and, if stopped suddenly, dangerous withdrawal reactions including seizures; therefore, it must never be stopped abruptly.FDA Access Data+2FDA Access Data+2

3. Trihexyphenidyl
   Trihexyphenidyl is an anticholinergic drug used as an add-on treatment for parkinsonism and dystonia. It may reduce tremor and some twisting movements in children when carefully titrated. The mechanism is blocking acetylcholine in parts of the brain that balance dopamine. Doses are slowly built up, usually given two or three times per day with food. Common side effects are dry mouth, constipation, blurred vision, confusion, and trouble urinating, so doctors use it cautiously in children.FDA Access Data+1

4. Amantadine
   Amantadine is an antiviral medicine that also has dopaminergic and NMDA-receptor blocking actions. In movement disorders, it can help reduce parkinsonian features and some dyskinesias. It is given in divided daily doses, with adjustments for kidney function. Side effects can include swelling of ankles, skin color changes, confusion, and hallucinations, especially at higher doses or in sensitive patients, so close monitoring is needed.FDA Access Data+1

5. Clonazepam (KLONOPIN)
   Clonazepam is a benzodiazepine that enhances the calming effect of GABA in the brain. It is used for seizures, myoclonic jerks, and sometimes dystonia or severe anxiety. Doses are started very low and increased gradually, usually given two or three times per day. Side effects include drowsiness, poor coordination, drooling, breathing depression, and dependence, so long-term use is carefully reviewed, and tapering must be slow under medical supervision.FDA Access Data+2FDA Access Data+2

6. Diazepam (VALIUM)
   Diazepam is another benzodiazepine used to stop acute seizures or severe muscle spasms. It can be given orally, by injection, or via rectal preparations in emergencies. It acts quickly to calm abnormal electrical activity and reduce spasticity. Because it can cause strong sedation, breathing suppression, and dependence, it is usually reserved for short-term or rescue use, with careful dose guidance.FDA Access Data+1

7. Valproic acid / divalproex (DEPAKENE, DEPAKOTE)
   Valproic acid is a broad-spectrum anti-seizure medicine that can help generalized seizures, myoclonic jerks, and mood instability. It increases GABA levels and has multiple actions on brain ion channels. Doses are based on weight and blood levels, typically divided two or three times daily. Serious possible side effects include liver failure, pancreatitis, weight gain, hair loss, and birth defects, so regular blood tests and careful risk–benefit discussions are essential, especially in young children.FDA Access Data+2FDA Access Data+2

8. Levetiracetam (KEPPRA, SPRITAM)
   Levetiracetam is a modern anti-seizure drug often used in children because it has fewer drug interactions. It binds to synaptic vesicle protein 2A and reduces abnormal firing of neurons. Doses are weight-based, given twice daily, and can be increased fairly quickly. Side effects may include irritability, mood swings, fatigue, and rarely allergic reactions, so behavior monitoring is important.FDA Access Data+2FDA Access Data+2

9. Gabapentin (NEURONTIN and related forms)
   Gabapentin modulates calcium channels in nerves and is used for neuropathic pain and some seizure types. In this syndrome, it may help treat neuropathic pain, discomfort from spasticity, or sleep problems. It is usually given three times daily, starting with a low dose and titrating up. Common side effects are sleepiness, dizziness, weight gain, and swelling of the legs.FDA Access Data+2FDA Access Data+2

10. Risperidone (RISPERDAL)
    Risperidone is an atypical antipsychotic that blocks dopamine and serotonin receptors. It is used in children for irritability, aggression, and serious behavior problems in several neurodevelopmental conditions. Doses start very low (like 0.25–0.5 mg/day) and increase slowly. Side effects can include weight gain, sleepiness, hormonal changes like increased prolactin, and extrapyramidal side effects, so close monitoring and the lowest effective dose are important.FDA Access Data+2FDA Access Data+2

11. Tetrabenazine (XENAZINE and related VMAT2 inhibitors)
    Tetrabenazine reduces release of dopamine by blocking VMAT2 and is used mainly for chorea in Huntington’s disease. In very severe chorea in rare childhood conditions, specialists sometimes consider it off-label. Doses are increased gradually, divided across the day. Side effects include depression, sleepiness, parkinsonism, and a risk of suicidal thoughts, so it requires intense psychiatric and neurological monitoring.FDA Access Data+2FDA Access Data+2

12. Melatonin
    Melatonin is a hormone that helps control the sleep–wake cycle. As a supplement, it is often used to improve sleep onset and quality in children with neurodevelopmental disorders. It is usually given once in the evening, around 30–60 minutes before bedtime. Side effects are generally mild and can include morning sleepiness, vivid dreams, or headaches. Even though it is available over the counter in many places, dose and timing should still be discussed with a doctor.PMC+1

13. Selective serotonin reuptake inhibitors (SSRIs, e.g., fluoxetine)
    SSRIs are antidepressants that increase serotonin levels and may help with depression, anxiety, or obsessive behaviors in older children and adolescents with chronic neurologic disease. Doses start very low and are increased slowly. Side effects include stomach upset, sleep changes, activation or irritability, and rarely suicidal thoughts in youth, so careful monitoring by a child psychiatrist is necessary.PMC+1

14. Anticholinergic eye drops or patches for drooling (e.g., atropine drops sublingual, scopolamine patch)
    Some children have severe drooling and saliva control problems. Small doses of anticholinergic medicines can reduce saliva. They work by blocking parasympathetic input to salivary glands. Side effects are dry mouth, constipation, blurred vision, and sometimes confusion, so dosing must be cautious and reviewed regularly.PMC+1

15. Laxatives (e.g., polyethylene glycol)
    Because many medicines and limited mobility cause constipation, stool softeners and osmotic laxatives are often needed. They pull more water into the bowel and help stool move more easily. Doses are adjusted to produce soft stools once per day. Side effects can include bloating or cramps if given too quickly.PMC

16. Proton pump inhibitors or H2 blockers (e.g., omeprazole, ranitidine alternatives)
    Reflux and swallowing problems can cause heartburn and risk of aspiration. Acid-reducing drugs protect the esophagus by lowering stomach acid. They are given once or twice daily before meals. Side effects can include diarrhea, headache, and, with long use, changes in mineral absorption, so treatment is reviewed regularly.PMC

17. Bronchodilators and inhaled steroids (if chronic lung problems)
    For children with recurrent chest infections, inhaled bronchodilators and sometimes inhaled steroids may help keep airways open and reduce inflammation. These are given through inhalers or nebulizers with spacers. Side effects include fast heart rate, tremor, or oral thrush, so mouth rinsing and correct inhaler technique are important.PMC+1

18. Antiepileptic rescue medicines (e.g., intranasal midazolam, rectal diazepam)
    For prolonged seizures, families may be given rescue medications to stop seizures before reaching hospital. These act quickly on GABA receptors to calm brain activity. Doses are strictly weight-based, and training is needed to use them safely; side effects mainly include sedation and possible breathing depression, so emergency plans are essential.FDA Access Data+1

19. Vitamin D and calcium supplements (when on certain drugs or immobile)
    Some anti-seizure drugs and immobility increase risk of weak bones. Vitamin D and calcium help keep bones stronger. Doses are based on blood levels and age. Side effects are uncommon at standard doses but very high doses can cause high calcium levels, so monitoring is required.FDA Access Data+1

20. Multivitamin and mineral supplements
    Chronic illness, feeding problems, and limited diets can cause vitamin and mineral gaps. A balanced pediatric multivitamin may be used to support general health. The mechanism is simple replacement of small amounts of many nutrients required for normal cell function. The dose is usually once daily, matching the child’s age range.PMC+1

---

Dietary molecular supplements

Evidence for these in this specific rare syndrome is limited. They are discussed as general neuro-nutritional supports; any use must be supervised by a doctor or dietitian.

1. Omega-3 fatty acids (EPA/DHA) – May support brain cell membranes and reduce inflammation. Typically given as fish-oil capsules or liquids, with doses adjusted by weight. Mechanism: omega-3s become part of neuron membranes and can modulate inflammatory pathways and neurotransmission.PMC

2. Vitamin D – Important for bone health, immune function, and possibly brain health. Paediatric doses are weight- and level-based. Mechanism: acts as a hormone that influences calcium balance, immune cells, and many genes in the brain and body.FDA Access Data+1

3. Vitamin B12 – Needed for nerve myelin and red blood cells. Given orally or by injection if deficient. Mechanism: cofactor in methylation and myelin synthesis; deficiency can worsen neuropathy and cognitive function.ERN RND+1

4. Folate (vitamin B9) – Works with B12 in DNA synthesis and methylation. Supplemented if low or if the child is on certain drugs that lower folate. Mechanism: supports cell division and repair, especially in rapidly dividing cells and the nervous system.ERN RND+1

5. Coenzyme Q10 (CoQ10) – A mitochondrial cofactor that helps energy production. Sometimes used when mitochondrial dysfunction is suspected. Mechanism: carries electrons in the mitochondrial respiratory chain and also acts as an antioxidant, possibly improving cell energy.ERN RND+1

6. L-carnitine – Helps transport fatty acids into mitochondria for energy. May be used if valproate or mitochondrial problems are present. Mechanism: improves fatty-acid oxidation and can reduce build-up of toxic metabolites.FDA Access Data+1

7. Magnesium – Supports muscle and nerve function and may help with cramps or constipation. Mechanism: acts as a cofactor in many enzyme reactions and modulates NMDA receptors in neurons.PMC+1

8. Zinc – Important for immune system, wound healing, and brain development. Mechanism: part of many enzymes and transcription factors; deficiency can slow growth and impair immunity.Global Genes+1

9. Probiotics – Helpful bacteria that support gut health, which is important in children with feeding issues and constipation. Mechanism: change gut flora balance, improve gut barrier function, and may modulate immune responses.PMC+1

10. Antioxidant vitamins (vitamin C and E) – Protect cells from oxidative stress. Mechanism: neutralize free radicals that can damage cell membranes and proteins; theoretical benefit where ongoing neurodegeneration and oxidative injury occur.PMC+1

---

Immunity-supporting, regenerative and stem-cell-related therapies

1. Intravenous immunoglobulin (IVIG)
   IVIG is a purified antibody product from donor plasma. In some autoimmune or inflammatory brain conditions with movement disorders, IVIG can calm abnormal immune attacks. It is given as a slow intravenous infusion at intervals decided by specialists. Mechanism: modulates the immune system, blocks harmful antibodies, and balances immune cell activity. Side effects can include headache, fever, allergic reactions, and, rarely, kidney problems or blood clots.ERN RND+1

2. Corticosteroids and other immunosuppressants
   If part of the condition is thought to involve inflammation or autoimmunity, courses of steroids or other immunosuppressants may be considered. They reduce immune activity and swelling in the brain. Mechanism: broad dampening of immune responses and cytokine production. Side effects include weight gain, high blood pressure, infection risk, and mood changes, so treatment is carefully weighed and monitored.ERN RND+1

3. Hematopoietic stem cell transplantation (HSCT)
   For a few genetic neurodegenerative diseases, early HSCT may slow progression by replacing defective blood-derived or immune cells. It involves chemotherapy, then infusion of donor stem cells. Mechanism: donor stem cells repopulate the bone marrow with cells that produce missing or corrected enzymes, indirectly helping the brain. Risks include infection, graft-versus-host disease, and treatment-related mortality, so it is only done in selected cases.ERN RND+1

4. Mesenchymal stem cell therapies (experimental)
   Some research trials use mesenchymal stem cells from bone marrow or umbilical cord to try to support brain repair. Mechanism is thought to be release of growth factors and immune modulation rather than direct replacement of neurons. These therapies are mostly experimental, often in clinical trials, and not standard care. Families should avoid unregulated clinics.ERN RND+1

5. Gene-targeted therapies (experimental and future)
   As more genes causing this syndrome are discovered, gene-replacement or gene-editing therapies may become possible. These use viral vectors or other tools to deliver healthy copies of genes to cells. Mechanism: correcting the underlying genetic defect so cells can work more normally. Currently, such treatments for this exact syndrome are not available in routine care and may only exist as research.ERN RND+1

6. Growth factors and neuroprotective agents (research use)
   Some studies explore medicines that support neuron survival, such as agents acting on neurotrophic factors or mitochondrial function. Mechanisms include enhancing energy production, reducing oxidative stress, or promoting synaptic repair. These remain research-stage and are not standard treatment for this syndrome.ERN RND+1

---

Surgical and interventional procedures

1. Deep brain stimulation (DBS)
   DBS involves surgically placing electrodes in deep brain regions like the globus pallidus or subthalamic nucleus and connecting them to a pulse generator under the skin. For severe dystonia or parkinsonism that does not respond to medication, DBS can reduce abnormal movements and improve comfort. The mechanism is continuous electrical stimulation that changes abnormal firing patterns in motor circuits. It requires careful selection, imaging, and long-term programming by specialists.PMC+1

2. Intrathecal baclofen pump implantation
   For very severe spasticity, surgeons can place a small pump under the skin that delivers baclofen directly into the fluid around the spinal cord. This allows strong spasticity control with lower total doses and fewer whole-body side effects. The procedure includes placing a catheter into the spinal canal and connecting it to the pump. Regular refills and monitoring are needed.FDA Access Data+1

3. Orthopedic surgery for contractures and deformities
   Over time, tight muscles can pull bones into fixed abnormal positions, causing pain and difficulty in care. Orthopedic procedures like tendon lengthening, hip stabilization, or spinal fusion for scoliosis may be done. The purpose is to improve posture, reduce pain, and ease hygiene and sitting. Mechanism: surgically releasing or correcting abnormal bone and muscle alignment.PMC+1

4. Gastrostomy tube (G-tube) placement
   When swallowing becomes unsafe or very slow, a small feeding tube can be placed directly into the stomach through the abdominal wall. This allows safe delivery of nutrition, water, and medicines. The mechanism is bypassing the mouth and throat to reduce aspiration risk and support adequate calories. Parents are trained in tube care and feeding routines.Global Genes+1

5. Tracheostomy and airway surgery (in selected severe cases)
   If breathing muscles are weak or secretions are hard to manage, a tracheostomy (opening in the windpipe) may be considered. This can allow more effective suctioning and use of ventilators. The purpose is life support and comfort when less invasive methods are not enough. The mechanism is providing a stable airway route; however, it brings major care demands and ethical discussions and is not suitable for every family.PMC+1

---

Prevention and risk reduction

Because this is a genetic and very rare disease, we cannot fully prevent it, but we can reduce complications and support families:

1. Genetic counseling for parents and relatives – To understand inheritance, carrier status, and options in future pregnancies.Global Genes+1

2. Early diagnosis and referral to specialists – The sooner therapy starts, the better the chances of slowing complications.ERN RND+1

3. Regular vaccinations and infection prevention – To reduce infections that might worsen movement or seizures.PMC+1

4. Safe feeding and swallowing assessment – Early swallow studies and therapy to prevent aspiration pneumonia.Global Genes+1

5. Bone health monitoring – Vitamin D, calcium, and bone density checks when needed to prevent fractures.FDA Access Data+1

6. Regular physiotherapy and orthotic use – To prevent contractures and deformities from progressing.PMC+1

7. Fall-prevention measures at home – Removing hazards, using rails and supports, and supervising walking.PMC

8. Monitoring for mood and behavior changes – Early recognition of depression, anxiety, or irritability and timely counseling.PMC+1

9. Regular vision and hearing checks – To correct treatable sensory problems that worsen disability.PMC+1

10. Planning ahead for advanced care – Discussing future feeding, breathing support, and goals of care with the team before crisis happens.Global Genes+1

---

When to see doctors

Families should stay in regular contact with a pediatric neurologist and other team members. They should seek urgent medical help if seizures increase or become prolonged, if the child has trouble breathing, new choking episodes, high fever with confusion, sudden worsening of movements, or any new strong side effect after starting or changing a medicine. Routine reviews are needed to adjust therapies, update equipment, review growth and nutrition, and support emotional well-being. For future pregnancies, parents should see genetic counselors and high-risk obstetric teams early to discuss testing options.Global Genes+1

---

What to eat and what to avoid

1. Prefer balanced, nutrient-dense meals rich in fruits, vegetables, whole grains, and healthy fats to support overall health.PMC

2. Include adequate protein (eggs, fish, lentils, dairy) to maintain muscles, especially when mobility is limited.PMC

3. Use high-calorie, easy-to-swallow foods (smoothies, yogurts, purees) when chewing is weak to prevent weight loss.Global Genes+1

4. Encourage fiber-rich foods (fruits, vegetables, oats) and enough fluids to reduce constipation, unless restricted by the doctor.PMC

5. Ensure sufficient calcium and vitamin D through diet and supplements as advised by the care team.FDA Access Data+1

6. Limit very sugary drinks and junk foods that add calories without nutrients and may worsen weight or dental problems.PMC

7. Avoid hard, dry, or crumbly foods (chips, nuts, dry biscuits) if swallowing is unsafe, as they increase choking risk.Global Genes+1

8. Be cautious with very salty or heavily processed foods, especially if some medicines affect blood pressure or kidney function.FDA Access Data+1

9. Avoid giving herbal or internet-advertised “miracle” cures without checking with the specialist, as they may interact with medicines.PMC+1

10. Work with a dietitian to tailor the diet to the child’s stage of disease, energy needs, and cultural food preferences.PMC+1

---

Frequently asked questions

1. Is this disease curable?
   At present, there is no cure for childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder. Treatment focuses on controlling symptoms, supporting development, and preventing complications. Research into gene-targeted therapies and neuroprotective treatments is ongoing, but these are not yet part of routine care.Orpha+1

2. Will every child get worse at the same speed?
   No. The course is variable. Some children lose skills quickly; others decline more slowly. Factors like the exact gene mutation, early support, and co-existing problems such as seizures or infections can influence the speed of change. Regular assessments help track progression and adjust care.Global Genes+1

3. Can therapy really help if the disease is progressive?
   Yes. Therapies cannot stop the genetic disease, but they can greatly improve comfort, keep skills longer, and delay or reduce secondary problems like contractures, pain, and aspiration. Families often notice better quality of life and easier daily care when therapies are consistent.PMC+1

4. Which doctor should coordinate care?
   Usually a pediatric neurologist or pediatric neurogenetic specialist leads the team, working with rehabilitation doctors, therapists, dietitians, and others. In some places, a complex-care pediatrician or palliative care team helps coordinate appointments and long-term plans.PMC+1

5. Are all medicines mentioned above used in every child?
   No. Treatment is very individual. Some children may need several anti-seizure drugs but little help for behavior; others may focus more on movement medicines or feeding support. Doctors choose drugs based on the child’s main problems, age, other illnesses, and how well each medicine is tolerated.PMC+1

6. Are these medicines approved specifically for this syndrome?
   Most medicines listed are approved by the FDA for more common indications like epilepsy, parkinsonism, spasticity, or behavioral disorders, as shown in their labels on accessdata.fda.gov.FDA Access Data+3FDA Access Data+3FDA Access Data+3 In this rare syndrome they are usually used “off-label,” guided by experience in similar conditions.

7. Will my child need surgery?
   Not all children need surgery. Procedures like DBS, baclofen pumps, or feeding tubes are considered only when symptoms are very severe and other treatments have not worked well. The team weighs benefits, risks, and the family’s goals before suggesting surgery.PMC+2Physiopedia+2

8. Can special diets cure the disease?
   No specific diet is known to cure or stop this genetic neurodegenerative disorder. A healthy, tailored diet can maintain strength, prevent malnutrition, and support comfort, but it cannot reverse the underlying brain changes. Extreme diets should be avoided unless recommended by the medical team.PMC+1

9. Is stem cell therapy a proven treatment now?
   For this exact syndrome, stem cell therapies are experimental at best. Some may be offered only within regulated clinical trials with strict oversight. Commercial clinics that promise cures without solid evidence can be unsafe and expensive. Families should always discuss such offers with their neurologist.ERN RND+1

10. Can siblings also be affected?
    If the condition is autosomal recessive, each full sibling has a 25% chance of being affected, a 50% chance of being a healthy carrier, and a 25% chance of being neither, if both parents are carriers. Genetic counseling and testing can clarify risks for each family.Global Genes+1

11. What tests are needed to confirm the diagnosis?
    Doctors typically perform a detailed neurological exam, brain MRI, metabolic blood and urine tests, and then genetic testing such as targeted panels or exome sequencing. EEG is often used if seizures are suspected. Together, these tests help rule out treatable conditions and confirm the rare syndrome.ERN RND+2NCBI+2

12. Can early treatment change the long-term outlook?
    Early recognition and supportive treatment can reduce complications like contractures, aspiration, and severe malnutrition, which can indirectly improve survival and quality of life. However, the underlying genetic disease usually still progresses, and expectations should be realistic and compassionate.PMC+2Global Genes+2

13. How can parents cope emotionally?
    Living with a child who has a progressive neurodegenerative disease is very stressful. Many families benefit from counseling, support groups, respite care, and honest communication with the medical team. Accepting help from relatives, friends, and community services can ease the burden.Global Genes+1

14. Is it safe to use traditional or alternative remedies?
    Some traditional practices may be harmless and emotionally supportive, but others can interact with medicines or delay proper treatment. Families should always tell the medical team about any herbs, home remedies, or alternative therapies they are considering so safety can be checked.PMC+1

15. What is the most important thing for families to remember?
    The most important point is that families are not alone. Although this syndrome is rare, a coordinated team can provide medical care, therapy, equipment, and emotional support. Small improvements—better comfort, easier feeding, fewer infections—can make a big difference in daily life, even when a cure is not yet available.Global Genes+1

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 31, 2025.